RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells.
Neutrophil-like Monocytes Increase in Patients with Colon Cancer and Induce Dysfunctional TIGIT+ NK Cells.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
髓源性抑制细胞(MDSCs)是一个异质性免疫细胞家族,包括粒细胞型(CD14neg/CD15+/HLA-DRneg)和单核细胞型亚群(CD14+/CD15neg/HLA-DRneg)。在本研究中,我们发现在结直肠癌(CRC)患者的外周血(PB)和肿瘤组织中均显著增加的一群表达粒细胞标志物CD15的单核细胞。进一步的表型分析证实了该单核细胞亚群的粒细胞样特征,其与这些患者(pts)PB中粒细胞-单核细胞前体(GMPs)的增加相关。在机制上,该粒细胞样单核细胞群体通过诱导TIGIT并参与NKp30来抑制NK细胞活性。相应地,在CRC患者的PB和肿瘤组织中均发现TIGIT+ NK细胞频率增加且功能受损。总体而言,我们通过展示这种新型MDSC在PB和CRC组织中的增加,为CRC中发生的肿瘤免疫逃逸提供了新的机制解释,该细胞能够显著损害NK细胞的效应功能,因此代表了一个潜在的癌症免疫治疗靶点。
Myeloid-derived suppressor cells (MDSCs) are a heterogeneous family of immune cells including granulocytic (CD14neg/CD15+/HLA-DRneg) and monocytic subtypes (CD14+/CD15neg/HLA-DRneg). In the present study, we found a population of monocytes expressing the granulocyte marker CD15 that significantly increased in both peripheral blood (PB) and tumoral tissues of patients with colorectal cancer (CRC).
Further phenotypical analysis confirmed the granulocytic-like features of this monocyte subpopulation that is associated with an increase in granulocyte-monocyte precursors (GMPs) in the PB of these patients (pts).
Mechanistically, this granulocyte-like monocyte population suppressed NK cell activity by inducing TIGIT and engaging NKp30. Accordingly, an increased frequency of TIGIT+ NK cells with impaired functions was found in both the PB and tumoral tissue of CRC pts.
Collectively, we provided new mechanistic explanations for tumor immune escape occurring in CRC by showing the increase in this new kind of MDSC, in both PB and CRC tissue, which is able to significantly impair the effector functions of NK cells, thereby representing a potential therapeutic target for cancer immunotherapy.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。